Print Page  Close Window     


RSS Content


Vanda Pharmaceuticals Announces Participation at the Oppenheimer Specialty Pharma Summit Conference

WASHINGTON, Oct. 10, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it will host investor meetings at the Oppenheimer Specialty Pharma Summit Conference in New York City on Wednesday, October 11, 2017.

About Vanda Pharmaceuticals Inc.

Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.

Company Contact:
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

 

View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-the-oppenheimer-specialty-pharma-summit-conference-300534383.html

SOURCE Vanda Pharmaceuticals Inc.